Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of ALTEROLA BIOTECH INC. from 31 Mar 2023 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
ALTEROLA BIOTECH INC. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD history and change rate from 31 Mar 2023 to 30 Sep 2024.
  • ALTEROLA BIOTECH INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 30 Sep 2024 was $2,251,245, a 8.2% decline year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

ALTEROLA BIOTECH INC. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $2,251,245 -$170,307 -8.2% 30 Sep 2024 10-Q 29 Nov 2024 2025 Q2
Q2 2024 $1,464,817 -$11,630,156 -114% 30 Jun 2024 10-Q/A 25 Nov 2024 2025 Q1
Q1 2024 $1,329,601 -$11,090,745 -114% 31 Mar 2024 10-Q 29 Nov 2024 2025 Q2
Q3 2023 $2,080,938 30 Sep 2023 10-Q 29 Nov 2024 2025 Q2
Q2 2023 $10,165,339 30 Jun 2023 10-Q/A 25 Nov 2024 2025 Q1
Q1 2023 $9,761,144 31 Mar 2023 10-Q/A 25 Nov 2024 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.